← Browse by Condition
Medical Condition

digestive system cancers

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 2
NCT06099821 Phase 2
Recruiting

KN046 Plus Regorafenib or Apatinib in MSI-H Digestive System Cancers Resistant to PD-1/PD-L1 Blockade

Enrollment
39 pts
Location
China
Sponsor
Peking University Cancer Hospi...
View Trial →